Investigating how oxytocin affects blood sugar levels
Official title: The Role of Oxytocin in Regulating Blood Glucose
Run by University Hospital, Gentofte, Copenhagen · NCT06334172 · Data updated 2026-11-12
This study is testing whether oxytocin can affect blood sugar levels and hormone release in healthy men with a normal weight.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 50 Years |
| Sex | Men only |
| Enrollment | 20 (estimated) |
| Sponsor | University Hospital, Gentofte, Copenhagen Academic / other |
| Locations | 1 site (Hellerup, Capital Region) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | April 4, 2024 |
| Trial ID | NCT06334172 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy men with a body mass index between 19 and 25 kg/m2.
✕Probably not a fit
Patients with diabetes or significant health issues such as heart, liver, or kidney disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines the impact of oxytocin on insulin and glucagon secretion in healthy men with a body mass index under 27 kg/m2. Participants will undergo a graded glucose infusion test while receiving either synthetic oxytocin or a placebo in a randomized, double-blinded manner. The research aims to determine how oxytocin influences glucose-stimulated hormone secretion and will also measure changes in various metabolic markers.
Why it matters
Potential benefit: If successful, this study could lead to new treatments for glucose metabolism disorders, potentially improving blood sugar regulation.
How similar studies have gone: While the role of oxytocin in glucose metabolism is being explored, this specific approach is relatively novel and has not been extensively tested in similar studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI 19-25 kg/m2 Exclusion Criteria: * Diabetes * Heart-, liver or kidney disease * More than 14 units of alcohol weekly, or drug abuse * Smoking or any kind of nicotine products * Alanin aminotransferase (ALAT) ≥ 2 × normal range * Estimated glomerular filtration rate (eGFR) \< 60 ml/min/1,73m2 or creatinine above normal range * Blood pressure \> 140/90 * Hemoglobin \< normal range * Corrected QT Interval (Qtc) \>0,45 sec. at electrocardiogram (ECG) at screening * Known disease in the pituitary gland or previous pituitary surgery * Any other disease/condition which the trial managers believe may affect participation in the trial
Where it's running
-
Center for Clinical Metabolic Research, Gentofte Hospital
Hellerup, Capital Region, Denmark Recruiting
Study contacts
- Study coordinator: Vivian Kliim-Hansen, MD
- Email: vivian.kliim-hansen@regionh.dk
- Phone: +4524476875
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chlorhexidine mouthwash and post-meal blood sugar in healthy adults
This study will test whether rinsing with chlorhexidine mouthwash changes how much blood sugar rises after eating in healthy adults.
-
Test with Dexcom G7 glucose monitor during heart surgery
Researchers will see if the Dexcom G7 continuous glucose monitor accurately reflects blood sugar during cardiopulmonary bypass and in the ICU after heart surgery in adults.
-
Investigating the safety and effectiveness of porcine pancreatic cells in patients with Type 1 diabetes
This study is testing if using pig pancreas cells can help adults with tough-to-manage Type 1 diabetes feel better and avoid dangerous low blood sugar episodes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.